Next week, 121 companies from the S&P 500, including major players in healthcare and industrials like Pfizer, AbbVie, and Merck & Co., will report earnings, potentially influencing market dynamics amidst a projected earnings decline of about 6.4% per year. As these firms prepare to release their figures, analysts expect that their results could significantly impact sentiment in the broader market and investor strategies.